Ignite Creation Date:
2025-12-25 @ 3:02 AM
Ignite Modification Date:
2025-12-31 @ 2:12 AM
Study NCT ID:
NCT01897233
Status:
COMPLETED
Last Update Posted:
2017-06-20
First Post:
2013-07-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Lumacaftor in Combination With Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Study Modules
Identification Module
Status Module
Sponsor Collaborators Module
Oversight Module
Description Module
Conditions Module
Design Module
Arms Interventions Module
Outcomes Module
Eligibility Module
Contacts Locations Module
References Module
Adverse Events Module
Baseline Characteristics Module
Participant Flow Module